FDA Inspection 904022 — R-Pharm Germany GmbH
The FDA completed an inspection of R-Pharm Germany GmbH on November 7, 2014 in Illertissen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 7, 2014
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Illertissen (Germany)